🔴 Painreform is trading 6.5% down in pre-market; reason remains unclear

Painreform is trading at $0.71, down 6.45% in pre-market; the reason for the decline remains unclear.

• No verified Painreform-specific announcement explaining the October 28 pre-market decline surfaced in the search.
• The latest identified company update was October 23, covering cash, OcuRing-K trial plans and GridFeed strategy—not a new overnight catalyst.
• Major U.S. indices were modestly higher in the supplied market context; no volume data was available.